What is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), consisting of all 44 amino acids of human GHRH with a trans-3-hexenoic acid modification at the N-terminus. This modification enhances the peptide’s stability and bioavailability compared to native GHRH, making it a valuable research tool for studying the growth hormone axis.
As a GHRH analog, tesamorelin acts specifically on the anterior pituitary gland to stimulate the synthesis and secretion of endogenous growth hormone (GH). Unlike exogenous growth hormone administration, tesamorelin preserves the pulsatile nature of GH release and maintains feedback regulation through the hypothalamic-pituitary axis.
Mechanism of Action
Tesamorelin binds to GHRH receptors (GHRH-R) on somatotroph cells in the anterior pituitary. These receptors are G-protein-coupled receptors that, upon activation, stimulate adenylyl cyclase, increase intracellular cAMP levels, and activate protein kinase A (PKA). This signaling cascade promotes both the transcription of the GH gene and the exocytosis of stored GH granules.
The peptide’s mechanism preserves physiological GH regulation because it works upstream of GH itself. Somatostatin (the endogenous GH-inhibiting hormone) continues to function normally, ensuring that GH release remains pulsatile rather than continuous — a critical distinction from direct GH administration.
Research has shown that tesamorelin produces dose-dependent increases in GH secretion, with peak levels occurring approximately 30-60 minutes post-administration in experimental models.
Key Research Applications
Lipodystrophy Research
Tesamorelin has been extensively studied in the context of visceral adipose tissue (VAT) accumulation. Research has demonstrated significant reductions in trunk fat, particularly visceral adiposity, while preserving subcutaneous fat and lean body mass. This selective effect on visceral fat makes it particularly interesting for metabolic research.
Growth Hormone Axis Studies
As a GHRH analog, tesamorelin is used extensively in research studying the GH/IGF-1 axis. Studies have examined its effects on IGF-1 levels, GH pulsatility patterns, and the interplay between GHRH and somatostatin in regulating growth hormone secretion.
Metabolic Research
Research has investigated tesamorelin’s effects on triglyceride levels, cholesterol profiles, and markers of cardiovascular risk. Studies have shown improvements in lipid parameters that may be related to both direct GH effects and indirect changes in body composition.
Cognitive Research
Emerging research has explored the relationship between GHRH analogs and cognitive function. Preliminary studies have investigated tesamorelin’s potential effects on memory, executive function, and biomarkers of neurodegeneration, given the known expression of GH and IGF-1 receptors in the brain.
Structure and Properties
- Molecular Formula: C221H366N72O67S
- Molecular Weight: ~5,135.9 Da
- Amino Acid Count: 44
- Modification: Trans-3-hexenoic acid at N-terminus
- Storage: Lyophilized at -20°C; reconstituted at 2-8°C
- Solubility: Soluble in sterile water and bacteriostatic water
- Purity: Research-grade typically ?98% by HPLC
Tesamorelin vs Other GH Secretagogues
Unlike GH-releasing peptides (GHRPs) such as ipamorelin that act through the ghrelin receptor, tesamorelin works exclusively through the GHRH receptor. This distinction is important for researchers, as the two pathways involve different signaling mechanisms and produce different patterns of GH release. Many research protocols examine both GHRH analogs and GHRPs for comparative analysis.
Handling and Storage
Tesamorelin should be stored as lyophilized powder at -20°C. Reconstitute with bacteriostatic water and store reconstituted solutions at 2-8°C for up to 21 days. The peptide is sensitive to heat and light; protect from both during handling. Use standard aseptic technique during reconstitution.
Related Peptides
- Ipamorelin – Growth hormone releasing peptide (GHRP)
- CJC-1295 No DAC – Modified GHRH analog
- MOTS-C – Mitochondrial-derived peptide with metabolic effects
Conclusion
Tesamorelin occupies a unique position in peptide research as the most extensively studied GHRH analog. Its ability to stimulate endogenous, pulsatile GH release while preserving physiological feedback mechanisms makes it an essential research tool for studying the growth hormone axis, body composition, and metabolic regulation.
All products are sold strictly for research purposes only. Not for human consumption.
Related Articles
All products are sold strictly for research purposes only. Not for human consumption.